Cargando…
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363281/ https://www.ncbi.nlm.nih.gov/pubmed/35913607 http://dx.doi.org/10.1007/s00415-022-11300-x |
| _version_ | 1784764896095764480 |
|---|---|
| author | Kreft, Karim L. Robertson, Neil P. |
| author_facet | Kreft, Karim L. Robertson, Neil P. |
| author_sort | Kreft, Karim L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9363281 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93632812022-08-11 Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment Kreft, Karim L. Robertson, Neil P. J Neurol Journal Club Springer Berlin Heidelberg 2022-08-01 2022 /pmc/articles/PMC9363281/ /pubmed/35913607 http://dx.doi.org/10.1007/s00415-022-11300-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Journal Club Kreft, Karim L. Robertson, Neil P. Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment |
| title | Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment |
| title_full | Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment |
| title_fullStr | Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment |
| title_full_unstemmed | Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment |
| title_short | Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment |
| title_sort | innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment |
| topic | Journal Club |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363281/ https://www.ncbi.nlm.nih.gov/pubmed/35913607 http://dx.doi.org/10.1007/s00415-022-11300-x |
| work_keys_str_mv | AT kreftkariml innovativebiomarkerstopredictunfavourableoutcomesafterinitiatingmultiplesclerosistreatment AT robertsonneilp innovativebiomarkerstopredictunfavourableoutcomesafterinitiatingmultiplesclerosistreatment |